rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2008-7-29
|
pubmed:abstractText |
Human cytochrome P450 2D6 (CYP2D6) genotype may affect the efficacy of tamoxifen treatment in Caucasian women with breast cancer. The most common polymorphism of CYP2D6 in Chinese women is variant 10 (188 C to T).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1569-8041
|
pubmed:author |
pubmed-author:FOXJ TJT,
pubmed-author:FanTT,
pubmed-author:FayWW,
pubmed-author:LiPP,
pubmed-author:LiuKK,
pubmed-author:OOIS KSK,
pubmed-author:OuyangTT,
pubmed-author:ShiLL,
pubmed-author:SunYY,
pubmed-author:WangTT,
pubmed-author:WuYY,
pubmed-author:XieYY,
pubmed-author:XuYY,
pubmed-author:YaoLL
|
pubmed:issnType |
Electronic
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1423-9
|
pubmed:meshHeading |
pubmed-meshheading:18407954-Adult,
pubmed-meshheading:18407954-Aged,
pubmed-meshheading:18407954-Antineoplastic Agents, Hormonal,
pubmed-meshheading:18407954-Asian Continental Ancestry Group,
pubmed-meshheading:18407954-Breast Neoplasms,
pubmed-meshheading:18407954-Cytochrome P-450 CYP2D6,
pubmed-meshheading:18407954-Disease-Free Survival,
pubmed-meshheading:18407954-Female,
pubmed-meshheading:18407954-Genotype,
pubmed-meshheading:18407954-Humans,
pubmed-meshheading:18407954-Middle Aged,
pubmed-meshheading:18407954-Tamoxifen
|
pubmed:year |
2008
|
pubmed:articleTitle |
Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment.
|
pubmed:affiliation |
Breast Center.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|